Floatz logo

(RS)-KETOPROFEN

Sciatica

University Hospital, GrenobleSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

19 Active assets in the Sciatica cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
University of Miami
Phase 4BBB
LIDOCAINE
C.L.A.Vleggeert-Lankamp
Phase 4BBB
NEPENTHE
Akdeniz University
Phase 4BB
Naproxen
Ostfold Hospital Trust
Phase 4BB
PREDNISONE TABLETS
Kaiser Permanente
Phase 3BB

View all 45 →

Same molecule, other indications

(RS)-KETOPROFEN is also rated in:

Pain ManagementDormant
BB
Indicative ·
64 / 100
View asset →
Pain, PostoperativeDormant
BB
Indicative ·
64 / 100
View asset →
post-operative pain, non-human animalDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →